Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2017-11-28

Clinical Trial Update: Omega3 PUFA in Head Trauam [NA]

View source ↗

Summary

This clinical trial update concerns omega-3 polyunsaturated fatty acids for traumatic brain injury, but the trial phase and current status are not specified.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Omega-3 polyunsaturated fatty acids (omega-3 polyunsaturated fatty acids)

Snippet

Sponsor: Mansoura University | Conditions: Traumatic Brain Injury | NA | Status: UNKNOWN